Gentis
Company

Last deal

$548.26K

Amount

Venture - Series Unknown

Stage

19.07.2010

Date

2

all rounds

$10.55M

Total amount

date founded

Financing round

General

About Company
Gentis develops biomaterials-based products for early-stage degeneration of the spine.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2000

Number of employees

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

Founded in 2000 and headquartered in Wayne, Pennsylvania, Gentis is a provider of minimally invasive, patented biomaterials-based products designed to treat early-stage degeneration of the spine. Their flagship product, DiscCell, is an injectable, in-situ setting, radio-opaque, non-hydrogel polymer material that augments or replaces the diseased nucleus pulposus of the spinal disc. This innovative solution enables patients to prevent a recurrence of back or leg pain at the treatment site, making it a promising alternative to traditional spine surgery.
Contacts

Contact Email

Phone number

Social url

Similar Companies
1000
Regentis Biomaterials

Regentis Biomaterials

Regentis Biomaterials develops proprietary hydrogels for tissue regeneration.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Or Akiva, Israel

total rounds

5

total raised

$36.08M
Biologics 4 Life

Biologics 4 Life

Biologics 4 Life is an early-stage orthobiologics company developing patented biomaterials for bone regeneration.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical Device

Location

Pertuis, France

total rounds

1
BioChange Ltd.

BioChange Ltd.

BioChange has developed an injectable scaffold that stimulates tissue repair and regeneration.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Yokne'am Illit, Israel

total rounds

1
Kuros Biosciences

Kuros Biosciences

Kuros Biosciences AG is a Swiss company that develops innovative products for tissue repair and regeneration.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

8952 Schlieren, Switzerland

total rounds

9

total raised

$82.17M

Financials

Funding Rounds
2
2

Number of Funding Rounds

$10.55M

Money Raised

Their latest funding was raised on 19.07.2010. Their latest investor Matignon Investissement & Gestion. Their latest round Venture - Series Unknown

Date 
Funding Round 
Investors 
Money Raised 
Lead 
Easton Capital

Easton Capital

Easton Capital Investment Group is a venture capital firm that manages $200 million on behalf of institutional investors.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Financial Services, Venture Capital, Health Care

Location

New York, NY, USA

count Of Investments

59

count Of Exists

17
Pappas Ventures

Pappas Ventures

Pappas Ventures is a venture capital firm that focuses on investing in early-stage life science companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Biotechnology, Venture Capital

Location

Durham, NC, USA

count Of Investments

45

count Of Exists

17
Co-Investors
Investors
5
2

Number of lead investors

5

Number of investors

Investor 
Lead 
Round 
Partners 
Matignon Investissement & Gestion

Matignon Investissement & Gestion

Matignon Investissement & Gestion is a renowned VC founded in 1996.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Real Estate, Real Estate Investment, Financial Services

Location

Paris, France

count Of Investments

5
Easton Capital

Easton Capital

Easton Capital Investment Group is a venture capital firm that manages $200 million on behalf of institutional investors.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Financial Services, Venture Capital, Health Care

Location

New York, NY, USA

count Of Investments

59

count Of Exists

17
Francisco Garcia

Francisco Garcia

Frank has more than twenty-five years experience as a principal investor and investment banker. Prior to joining Easton in 2000, he was the head of Corporate Finance at Cramer Rosenthal McGlynn, LLC, a large funds management and private equity firm. Previously, he ran Neptune Management Company (a manager of funds and accounts investing in special situations and distressed securities); was a senior executive in a distressed securities investment vehicle and served as a Vice President in Corporate Finance at Kidder, Peabody & Co. and was an attorney with Sullivan & Cromwell. Frank currently serves on the Boards of Archibald, Autonet, Gentis and TransMolecular, and is a Board observer of CardioMEMS. Frank received a JD degree from Harvard Law School and an AB degree from Harvard College.

current job

Easton Capital
Easton Capital
Pappas Ventures

Pappas Ventures

Pappas Ventures is a venture capital firm that focuses on investing in early-stage life science companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Biotechnology, Venture Capital

Location

Durham, NC, USA

count Of Investments

45

count Of Exists

17

People

Founders
2

Charles Cohen

Charles Cohen, Ph.D. serves as the Vice President of Product Development at Gentis, Inc. Dr. Cohen co-founded Gentis in 2000. He is the co-inventor for the key patent applications surrounding gentis key technology for treating degenerated or herniated discs in the spine. He is an expert in the Mechanical and Biological Performance of reconstructed bone structures. Prior to Gentis, he co-founded Orthovita and served as its Director of Oral, Cranial and Facial Reconstruction until February 2000. Dr. Cohen serves as a Member of Surgical Advisory Board at Gentis, Inc. Dr. Cohen is an academically trained biomedical entrepreneur with expertise in applying biomedical technology to commercial opportunity. In 1992, he obtained Ph. D Bioengineering at the University of Pennsylvania's Program for Bioactive Materials Research and Tissue Engineering. He completed the Wharton School of Business Management Program at the University of Pennsylvania, while writing his dissertartation to prepare for his entrepreneurial carrier. He also has a B.S in Mechanical Engineering from Union College in New York.

organization founded

1

Charles Cohen

Paul Ducheyne

Paul Ducheyne has more than 30 years of scientific, technical, entrepreneurial and governance experience in the biomaterials, medical device, tissue engineering and controlled release fields, especially as it concerns orthopaedics, but also as it relates to cardiology, dentistry and medicine. He founded and was chairman of Orthovita, acquired by Stryker, and founded Gentis and, while on a 2 year leave from academia, directed its start-up phase.

current job

Gentis
Gentis

organization founded

1

Paul Ducheyne

Employee Profiles
4

David W. Anderson

President and CEO

Paul Ducheyne

Founder

Activity

Recent News
0